Account
Articles
19.03.2020
What is a Payer

"Payer" generally refers to people or bodies other than the patient that finance or refund the cost ...

Read more
Articles
29.05.2019
What are precision medicines

What is the future of precision medicine in the EU? The field of precision medicine is a complex are...

Read more
Case Studies
21.02.2019
Payer insights for clinical trials

Understanding payer value and evidence requirements to secure pricing and reimbursement for an oncol...

Read more
Case Studies
21.02.2019
Maximising product value through PSA

Supporting in identifying and obtaining payer scientific advice to inform a Phase III trial design.

Read more
Publications
17.01.2019
Early payer scientific advice procedures

The objective of this research was to understand the processes and outputs from different European p...

Read more
Publications
14.11.2018
ISPOR 2018 Companies market access training

Setting the price abtaining market access for a new pharmaceutical remains one of the biggest commer...

Read more
Publications
14.11.2018
ISPOR 2018 Key considerations for payer advice

The aim of this study is to compare the key aspects companies must consider when seeking HTA scienti...

Read more
Case Studies
21.09.2018
Payer value proposition development

Understanding payer value and evidence requirements to secure pricing and reimbursement for a novel ...

Read more
Articles
14.11.2016
Early scientific advice procedures in the EU

This analysis compares the different methods of seeking payer scientific advice, including EMA joint...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.